Kangjian Miaomiao (Hangzhou) Pharmaceutical Co., Ltd. announced that it has raised CNY 100 million in a round of funding on June 19, 2024. The transaction included participation from new investors Shanghai Kindly Enterprise Development Group Co.,LTD.,Xianju Blue Bay Health Industry Investment Partnership (Limited Partnership),Hangzhou Yika Venture Capital Fund Partnership (Limited Partnership) and returning investor Korea Investment Partners (Shanghai) Venture Capital Management Co., Ltd.
Shanghai Kindly Enterprise Development Group Co.,LTD.
Equities
603987
CNE100003076
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.04 CNY | +0.50% |
|
+0.50% | -36.69% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.69% | 361M | |
+28.34% | 2.62B | |
+28.15% | 2.48B | |
-47.44% | 2.31B | |
+36.67% | 2.07B | |
-31.46% | 2.04B | |
-24.50% | 1.61B | |
+13.96% | 1.43B | |
+36.22% | 1.33B | |
+18.21% | 1.27B |
- Stock Market
- Equities
- 603987 Stock
- News Shanghai Kindly Enterprise Development Group Co.,LTD.
- Kangjian Miaomiao Pharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Korea Investment Partners Venture Capital Management Co., Ltd., Shanghai Kindly Enterprise Development Group Co.,LTD. and other investors